US 11453683
KRas G12D inhibitors
granted A61PA61P35/00
Quick answer
US patent 11453683 (KRas G12D inhibitors) held by Mirati Therapeutics, Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 84
- CPC classes
- A61P, A61P35/00